Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03263910Phase 3Completed
Phase 3, randomised, double-blind trial of L-menthol preparation NPO-11, sponsored by Nihon Pharmaceutical. Primary endpoint: Proportion of patients with no gastric peristalsis at 15 minutes. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03263910.